A retrospective, chart review study analysing wear-off phenomenon of calcitonin gene-related peptide (CGRP) monoclonal antibody (MAB) treatment in patients with chronic migraine
Latest Information Update: 01 Aug 2021
At a glance
- Drugs Erenumab (Primary) ; Fremanezumab (Primary) ; Galcanezumab (Primary)
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- 01 Aug 2021 New trial record
- 06 Jun 2021 Results presented at the 63rd Annual Scientific Meeting of the American Headache Society